Zhao Liu

Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state

Yong-mei Zhu, Yang Shen, Xiang-Qin Weng, 2018, Blood Cancer Journal.

Relationship between the Apolipoprotein AI, B gene polymorphism and the risk of non-traumatic osteonecrosis

Zhong-tang Liu, Ji-Min Yin, Zhao Liu, 2014, Lipids in Health and Disease.

Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma

Junmin Li, Xiaoyang Li, Wenfang Wang, 2016, Journal of experimental & clinical cancer research : CR.

HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells

G. Meng, Ting Shi, Yi-Lei Zhao, 2017, Nature Communications.

Synergistic effect of oridonin and a PI3K/mTOR inhibitor on the non-germinal center B cell-like subtype of diffuse large B cell lymphoma

Junmin Li, Xiaoyang Li, Wenfang Wang, 2016, Journal of Hematology & Oncology.

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group

Junmin Li, X. Hong, Junning Cao, 2012, Annals of Hematology.

The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China

Junmin Li, Weili Zhao, Yang Shen, 2014, Annals of Hematology.

Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma

Han Liu, Yingxiao Wang, Kai Xue, 2023, Cellular Oncology.

Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma

Junmin Li, Xiaoyang Li, Wenfang Wang, 2016, Journal of Experimental & Clinical Cancer Research.